Latest News and Press Releases

SEATTLE, May 30, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced the presentation of positive data from the company's ongoing trials of ONT-380, an orally active, reversible...

SEATTLE, May 26, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at the Jefferies 2015...

SEATTLE, May 11, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today reported financial results for the first quarter ended March 31, 2015. Net loss for the three months ended March 31,...

SEATTLE, May 4, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced that it will conduct a conference call on Monday, May 11, 2015 at 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to...

SEATTLE, March 10, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today reported financial results for the year and quarter ended December 31, 2014. Net loss for the year ended December 31,...

SEATTLE, March 3, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced the appointment of Steven P. James to its board of directors. "We are pleased to welcome Steve, with his...

SEATTLE, March 3, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced that it will conduct a conference call on Tuesday, March 10, 2015 at 4:30 p.m. Eastern Time (1:30 p.m....

SEATTLE, Feb. 17, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, is scheduled to present at two upcoming...

SEATTLE, Feb. 6, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced the pricing of previously announced concurrent but separate underwritten offerings of 13,500,000 shares of...

SEATTLE, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Oncothyreon Inc. (Nasdaq:ONTY) today announced that it intends to offer and sell shares of its Common Stock and Series B Convertible Preferred Stock in...